Jump to navigation
Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
One month ago, we headed to New Delhi, India for the Eleventh International Rotavirus Symposium.
In a new editorial published in PLOS NTDs, “The NTDs and Vaccine Diplomacy in Latin America: Opportunities for United States Foreign Policy,” Sabin Vaccine Institute (Sabin) President Dr.
By: Jonas Mbwangue, Senior Program Officer, Sabin Vaccine Institute Sustainable Immunization Program